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Abstract In an attempt to isolate protein kinase A anchoring
proteins (AKAPs) involved in vasopressin-mediated water
reabsorbtion, the complete sequence of the human AKAP Ht31
was determined and a partial cDNA of its rat orthologue (Rt31)
was cloned. The Ht31 cDNA includes the estrogen receptor
cofactor Brx and the RhoA GDP/GTP exchange factor proto-
lymphoid blast crisis (Lbc) sequences. The Ht31 gene was
assigned to chromosome 15 (region q24^q25). It encodes Ht31
and the smaller splice variants Brx and proto-Lbc. A protein of
the predicted size of Ht31 (309 kDa) was detected in human
mammary carcinoma and HeLa cells. Anti-Ht31/Rt31 antibodies
immunoprecipitated RhoA from primary cultured rat renal inner
medullary collecting duct cells, indicating an interaction between
the AKAP and RhoA in vivo. These results suggest that Ht31/
Rt31 represent a new type of AKAP, containing both an
anchoring and a catalytic domain, which appears to be capable of
modulating the activity of an interacting partner. Ht31/Rt31
have the potential to integrate Rho and protein kinase A
signaling pathways, and thus, are prime candidates to regulate
vasopressin-mediated water reabsorbtion. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Protein kinase A anchoring proteins (AKAPs) position pro-
tein kinase A (PKA) in the vicinity of its substrates and re-
strict its access to only a fraction of cellular substrates. The
tethering of PKA to subcellular compartments was the origi-
nal function attributed to AKAPs [1]. More recent evidence
indicates that they also tether whole signaling complexes to
speci¢c sites. AKAP79, for example, interacts with the post-
synaptic density proteins PSD95 and SAP97, which bind di-
rectly to glutamate receptors. Through this interaction,
AKAP79 anchors PKA, PKC and calcineurin in close prox-
imity of the receptors [2]. Herrgard et al. suggested a novel
function of the AKAPCE ; this AKAP may interact with a
TGFL family receptor [3].
Amino acids 635^1012 of the previously identi¢ed partial
open reading frame of the human AKAP Ht31 (1045 amino
acids) [1,4,5] are identical with amino acids 4^381 of the hu-
man breast cancer nuclear receptor-binding auxiliary protein
(Brx; Fig. 1A) [6]. Brx is an estrogen receptor cofactor which
augments gene activation by the receptor [6]. Amino acids
536^1230 of Brx are identical with residues 1^693 of the
RhoA-speci¢c GDP/GTP exchange factor (GEF) proto-lym-
phoid blast crisis (proto-Lbc). In addition, amino acids 1264^
1429 of Brx are identical with residues 727^893 of proto-Lbc.
Proto-Lbc belongs to the Dbl-homology (DH) family of
GEFs, characterized by the presence of tandem DH and
pleckstrin-homology (PH) domains (Fig. 1A) [6^9].
In this study we determined the full length Ht31 cDNA
sequence and cloned a partial cDNA of the rat orthologue
(Rt31) of Ht31. The full length Ht31 cDNA includes Brx and
proto-Lbc cDNA sequences. Rt31 interacts in vivo with
RhoA in primary cultured rat inner medullary collecting
duct (IMCD) cells, suggesting that Ht31/Rt31 may function
not only as PKA anchor, but also as a modulator of Rho
activity. Thus, Ht31/Rt31 may integrate PKA and Rho signals
and are, therefore, prime candidates for regulating processes
such as vasopressin-mediated water reabsorbtion which de-
pend on both PKA and Rho signaling [10^12].
2. Materials and methods
2.1. Expression cDNA library screening, PCR, RACE-PCR, and DNA
sequence analysis
A rat kidney Uni-ZAP XR expression cDNA library (Stratagene,
La Jolla, CA, USA) was screened using the type II regulatory subunit
of PKA (RII) overlay technique [13]. PCRs and RACE-PCRs were
performed using human mammary gland Marathon-Ready cDNA
and the Advantage cDNA polymerase mix according to the supplier’s
recommendations (Clontech, Heidelberg, Germany). Primer sequences
used for the ampli¢cation of seven cDNA fragments (Fig. 2) encoding
Ht31 are available upon request. Fragments 1 and 3^6 were cloned
into the vector pGem-T Easy (Promega, Mannheim, Germany) and
fragments 2 and 7 were cloned into the vector pCR-XL Topo (Invi-
trogen, Groningen, The Netherlands). Initially, sequencing was car-
ried out using vector sequencing primers and subsequently by primer
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 9 9 5 - 7
*Corresponding author. Fax: (49)-30-94793 109.
E-mail address: klussmann@fmp-berlin.de (E. Klussmann).
1 The cDNA sequences encoding Ht31 and Rt31 were deposited in
GenBank under the accession numbers AF387101 and AF387102
respectively.
Abbreviations: AKAP, A-kinase anchoring protein; AQP2, aquapor-
in-2; Lbc, lymphoid blast crisis; PKA, protein kinase A; IMCD,
inner medullary collecting duct; RII, type II regulatory subunit of
protein kinase A
FEBS 25388 26-10-01
FEBS 25388FEBS Letters 507 (2001) 264^268
walking (primer sequences are available upon request; Dye Termina-
tor FS 2.0 kit and ABI Prism 377 DNA sequencer, both Applied
Biosystems, Weiterstadt, Germany). Homology searches were per-
formed at GenBank, National Center for Biotechnology Information
(NCBI) (http://www.ncbi.nlm.nih.gov/blast), and at the Institute for
Genomic Research (http://www.tigr.org). Sequence translations and
alignments were carried out at the Human Genome Center, Baylor
College of Medicine (BCM Search Launcher; http://dot.imgen.bcm.
tmc.edu:9331/).
2.2. Cell culture, cell fractionation, and Western blotting
Primary cultured rat IMCD cells were prepared and cultured as
described [10,11,18]. The breast cancer cell lines ZR75-1 (a kind gift
of Prof. G. Schaller, Benjamin Franklin Klinikum, Free University of
Berlin, Germany) and HeLa cells (a kind gift of Dr. U. Vinkemeier,
Forschungsinstitut fu«r Molekulare Pharmakologie, Berlin, Germany)
were grown to con£uency in Dulbecco’s modi¢ed Eagle’s medium
containing 10% FCS. ZR75-1 cells were homogenized in phosphate-
bu¡ered saline using a glass/te£on homogenizer. Cell debris and nuclei
were removed by centrifugation (4000Ug, 10 min, 4‡C). The super-
natant was recentrifuged (150 000Ug, 1 h, 4‡C) to yield particulate (P;
pellet) and soluble (S; supernatant) fractions. P fractions (200 000Ug
pellets) from HeLa cells were prepared as previously described for
IMCD cells [10]. Ht31 was detected by Western blotting with a⁄n-
ity-puri¢ed antibodies 1965 or 3060 (dilutions 1:200; see below).
Horseradish peroxidase-conjugated goat anti-rabbit F(ab)2 fragments
(Dianova, Hamburg, Germany) were used as secondary antibody (di-
lution 1:3000).
2.3. Preparation of a⁄nity-puri¢ed anti-Ht31 antibodies
Rabbit polyclonal antiserum 1965 was raised against a peptide epi-
tope present in Rt31 (amino acids 369^383), Ht31 (amino acids 1556^
1570) and Brx (amino acids 172^186). Antiserum 3060 was raised
against amino acids 688^709 of Ht31 (Biogenes, Berlin, Germany).
A⁄nity-puri¢ed antibodies were prepared from the antisera by chro-
matography over the peptides used for immunization coupled to thio-
propyl Sepharose 6B (Amersham Pharmacia Biotech, Freiburg,
Germany).
2.4. Immunoprecipitation
IMCD cells were homogenized (20 strokes in a glass te£on homog-
enizer) in lysis bu¡er (20 mM Tris^HCl, pH 7.5, 1% Igepal, 1 mM
EDTA, pH 8.0, 1 mM EGTA, pH 8.0, 1 mM dithiothreitol, 0.5%
deoxycholate, 0.1% SDS, 1.5 mM MgCl2, 0.15 M NaCl). The homog-
enates were centrifuged (30 000Ug, 30 min, 4‡C) and the supernatant
from seven con£uent 65 mm Petri dishes incubated overnight with the
a⁄nity-puri¢ed anti-Ht31 antibody 3060 (40 Wg; see above) or pre-
immune serum (20 Wl). Protein A-conjugated agarose beads (Sigma,
Deisenhofen, Germany) were added (4 h). The beads were washed
three times with 1 ml of lysis bu¡er. Bound proteins were eluted
with Laemmli sample bu¡er (95‡C) and subjected to Western blot
analysis (see above) for the detection of RhoA with commercially
available antibodies (Santa Cruz Biotechnology, Heidelberg, Ger-
many).
3. Results
3.1. Cloning of a fragment of Rt31 and identi¢cation of the
Ht31 cDNA sequence
A partial cDNA clone (1747 bp; GenBank accession num-
ber AF387102) encoding a protein with homology to AKAP
Ht31 [4,5] was isolated from a rat kidney expression library.
In analogy to Ht31, the new protein was named R(attus)t31
(Fig. 1A). The overall amino acid sequence (582 residues)
identity between Rt31 and the corresponding region of Ht31
is 67.7%. Using Rt31 fragments and the RII overlay technique
[4,13], the RII-binding site of Rt31 was mapped to amino
acids 65^80 (SIEETATRIVEAVIKQ), corresponding to ami-
no acids 494^507 of Ht31 (data not shown). The amino acid
sequence identity in this region is 71.4%. Recombinant Rt31
protein bound PKA RIIL subunits with a Kd of 85 nM (data
not shown).
The sequence identity between Ht31, Brx and proto-Lbc in
the overlapping region (see Section 1) led to the hypothesis
that the unidenti¢ed 3P sequence of Ht31 includes the 3P se-
quence of Brx and proto-Lbc. Using these known cDNA se-
quences as the basis, both the 3P and 5P ends of Ht31 were
completed by a combination of conventional PCR, RACE-
PCR and data base analysis (Fig. 2; see Section 2). The two
large overlapping fragments 2 and 7 cover 8051 bp (Fig. 2).
The total length of the composite Ht31 cDNA is 8442 bp
from the start codon (contained within a Kozak consensus
sequence) [14] to the stop codon (GenBank accession number
Fig. 1. A: Schematic representation of Rt31, Ht31, Brx and proto-Lbc proteins. Rt31 and Ht31 represent partial sequences. Open reading
frames are indicated by boxes. Identical amino acid sequences are depicted by the same shading. RII, RII-binding site, DH and PH, dbl and
pleckstrin homology domains. Numbers indicate amino acids. B: Schematic representation of the full length Ht31 which posseses a unique
N-terminus and amino acids 4^1429 of Brx in its C-terminus. The ¢rst three amino acids of Brx are encoded by a GenBank clone which has
not yet been assigned to a chromosome, but most likely represents a separate exon of the Ht31 gene. The di¡erences between Ht31 and Brx in
this region (highlighted) most likely result from alternative splicing.
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AF387101). An Ht31-speci¢c probe which neither hybridizes
to Brx nor to proto-Lbc mRNAs detected several transcripts,
including one s 9.5 kb, in various human tissues (data not
shown). The mRNA species s 9.5 kb may encode the Ht31
protein (2813 amino acids; Fig. 1B). The protein has a calcu-
lated molecular weight of about 309 kDa and contains an
RII-binding domain (amino acids 1247^1266) and DH (amino
acids 1996^2226) and PH (amino acids 2240^2335) domains
(Fig. 1B). As all three domains are present in a single cDNA,
Ht31 may function not only as an AKAP, but also as an
estrogen receptor cofactor and/or as a RhoA-speci¢c GEF.
3.2. Analysis of Ht31 protein expression
The antibody 1965 is directed against a common epitope in
Ht31 (amino acids 1556^1570; Fig. 1B), Rt31 and Brx. Brx
has been identi¢ed in the human mammary carcinoma cell
line ZR75-1 [6]. Therefore, this cell line was chosen to test
whether the antibody detects Brx (about 170 kDa) and, addi-
tionally, a protein with the predicted size of Ht31 (309 kDa;
Fig. 3A). In the S fraction, where Brx is expected [6], the
antibody detected several proteins between 175 kDa and
about 220 kDa. These proteins are either absent from the
P fraction or present in the P fraction at much lower level.
The 175 kDa species may represent Brx. In addition, a single
protein signi¢cantly s 205 kDa was detected. In the P frac-
tion, the antibody detected one major protein 6 175 kDa and
again the s 205 kDa species, which may represent the full
length Ht31 protein (Fig. 3A, left panel). None of these pro-
teins was detected after preincubation of the antibody with
the peptide used for immunization (Fig. 3A, right panel), in-
dicating the speci¢city of the antibody and of the signals in
the left panel.
In HeLa cells, antibody 1965 detected several proteins
s 250 kDa in the P fraction (Fig. 3B). The antibody 3060,
directed against an Ht31 epitope neither present in Brx nor in
proto-Lbc, detected several proteins between 130 and s 250
kDa (Fig. 3B). Both antibodies recognized one protein s 250
kDa, suggesting that this may represent the full length Ht31,
which includes Brx in its C-terminus (Fig. 3B). The preim-
mune sera 1965 and 3060 recognized several proteins 6 250
kDa, but none of the proteins s 250 kDa were detected, in-
dicating that the latter are speci¢cally recognized by the anti-
bodies 1965 and 3060 (Fig. 3B). A protein of the expected size
of Ht31 was also detected in the mammary carcinoma cell line
MCF7 and in IMCD cells (data not shown).
3.3. The gene encoding Ht31, Brx and proto-Lbc is located on
chromosome 15 (region q24^q25)
Since Ht31, Brx and proto-Lbc cDNA share identical se-
quences, we investigated whether they are splice variants de-
rived from the same gene. The chromosomal localization of
the Ht31 gene was determined by a Blast search of the human
genome data base at the NCBI. Using the 8442 bp Ht31
Fig. 2. The strategy to obtain the full length Ht31 cDNA sequence
(8442 bp). The 3P end of the published partial Ht31 sequence [4,5]
shares identical sequences with the 5P end of Brx [6], whose 3P end
shares identical sequences with proto-Lbc [6]. Using these sequences
as the basis, the 3P end of Ht31 was obtained by successive PCR
ampli¢cations (fragment 1: 1715 bp; fragment 2: 4527 bp; fragment
3: 444 bp; for details, see Section 2). The 3P end, including an in-
frame stop codon, was identical with GenBank clone THC519492.
In an initial step for the identi¢cation of the 5P end, a RACE-PCR
product was obtained (fragment 4, 1656 bp) which was identical to
the 3P end of GenBank clone zr60f08.r1. The 5P end of this clone
was identical to the 3P end of GenBank clone THC510371. Primers
derived from this clone and from the Ht31 sequence allowed the
ampli¢cation of fragment 5 (2275 bp). This sequence allowed the re-
trieval of GenBank clones AA814393 and AI929065, both contain-
ing an in-frame start codon and an upstream, in-frame stop codon.
Primers derived from these sequences in combination with a primer
derived from Ht31 were used for the ampli¢cation of fragment 6
(1265 bp), containing the start codon of Ht31. Fragment 7 (4878
bp) overlapping fragment 2 was ampli¢ed from the 5P end to ex-
clude possible PCR artifacts.
Fig. 3. A: Detection of Ht31 and Brx in S and P fractions (60 Wg
protein/lane) from the human mammary carcinoma cell lines ZR-75-
1 by Western blotting using the antibody 1965 (left panel). In the
right panel, the antibody was preincubated with the peptide used
for immunization (1 h, 1000-fold excess). B: Detection of Ht31 in
P fractions from HeLa cells (60 Wg protein/lane) using antibody
1965 (lane 1) or 3060 (lane 3). In lanes 2 and 4, detection was car-
ried out using preimmune sera 1965 and 3060 respectively. *C, po-
tential full length Ht31 (calculated molecular weight of about 309
kDa); C, protein of about 175 kDa most likely representing Brx.
Signals were visualized using the Lumi-light Western blot detection
system and a Lumi-Imager F1 (Roche Diagnostics, Mannheim, Ger-
many).
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cDNA as query sequence, clone ref/NT 010343 was retrieved,
representing 529261 bp of human chromosome 15 (region
q24^q25) [15,16]. The analysis of ref/NT 010343 showed
that the Ht31 cDNA fragments were 98^100% identical with
sequences within ref/NT 010343, and covered 38 exons over
about 250 000 bp (Fig. 4). The intron/exon splice junctions are
conserved (data not shown). Since the complete Ht31 cDNA
sequence, including the Brx- and proto-Lbc-speci¢c sections,
could be assigned to a single gene, Brx and proto-Lbc repre-
sent smaller splice variants of Ht31. In agreement with this
¢nding, the Brx and proto-Lbc genes have previously been
mapped to the same chromosomal region [8,17]. The ¢rst
three amino acids of Brx are encoded by a GenBank clone
which has not yet been assigned to a chromosome, but most
likely represents a separate exon of the Ht31 gene (data not
shown).
3.4. Rt31 and RhoA interact in vivo
A possible interaction of Rt31 with RhoA was investigated
in immunoprecipitation experiments. Using the a⁄nity-puri-
¢ed antibody 3060 directed against an N-terminal Ht31 epi-
tope, Rt31 was immunoprecipitated from primary cultured
IMCD cells (Fig. 5). RhoA was detected in the immunopre-
cipitate, indicating an interaction between Rt31 and RhoA in
vivo. In precipitates obtained with preimmune serum, RhoA
was not detected, indicating the speci¢city of the immunopre-
cipitation. It should be noted that the experiment was per-
formed with non-overexpressing cells, underlining the signi¢-
cance of this ¢nding.
4. Discussion
The full length Ht31 cDNA sequence presented here in-
cludes an RII-binding domain and both the Brx and proto-
Lbc cDNA sequences. The multi-domain architecture of the
Ht31 protein implies that it may not only function as an
AKAP, but also as an estrogen receptor cofactor involved
in transcriptional regulation (Brx) and/or as a RhoA-speci¢c
GEF (proto-Lbc). The latter function suggests that Ht31 is
potentially capable of regulating cellular processes dependent
on both PKA and Rho signaling pathways. An interaction of
Rt31 and RhoA in vivo is indicated by the immunoprecipita-
tion of RhoA from primary cultured IMCD cells using anti-
Rt31/Ht31 antibodies (Fig. 5). This interaction seems to be of
physiological signi¢cance since the experiments were per-
formed in non-overexpressing cells. In renal inner medulla
vasopressin exerts its antidiuretic action by a process involv-
ing the translocation of water channels (aquaporin-2 (AQP2))
from intracellular vesicles to the apical membranes of princi-
pal cells. Previous work using primary cultured IMCD cells
has revealed that AQP2 translocation requires activation of
PKA, anchoring of PKA to AKAPs and a decreased Rho
activity [10^12]. Rt31/Ht31 may integrate PKA and Rho sig-
naling pathways, and thus, are prime candidates for regulat-
ing the translocation of AQP2 in renal principal cells.
In summary, the data presented here suggest that Ht31/
Rt31 does not only act as sca¡old for PKA. Rather, it is
the ¢rst AKAP capable of modulating the activity of the
signaling protein Rho.
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